Medicine
Citalopram 40 mg tablet
Citalopram 40 mg tablet is a generic prescription medicine for oral use, made by 21 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Citalopram tablets should be stored at 20-25°C (68 to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Citalopram
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 10 blister pack and 100 more
- Manufacturers
- Aurobindo PharmaIndiaCiplaIndiaTorrent PharmaceuticalsIndiaA-S Medication SolutionsAmneal PharmaceuticalsExelan PharmaceuticalsEpic PharmaMylan PharmaceuticalsAphena Pharma Solutions - Tennessee21 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Citalopram tablets should be stored at 20-25°C (68 to 77°F), excursions permitted between 15 and 30°C (59-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AB04 Citalopram
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 October 2004
- Identifiers
- RxCUI 309314, 200371, 283672DailyMed set ID c9809dfe-939e-4f9d-b6dd-f9808fd9f2b1, a8e8fde2-8392-4d5b-902b-e2b9dd55a02d, e0822069-9672-4d4c-bc1a-8739b0dd045c +33NDC 70518-2228, 76282-208, 82009-108 +33Application ANDA077534, ANDA077031, ANDA077042 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 21 labelers. The register lists 103 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 65862-007-01 | Aurobindo PharmaIndia | 28 October 2004 |
| 500 tablet, film coated in 1 bottle | 65862-007-05 | Aurobindo PharmaIndia | 28 October 2004 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-007-10 | Aurobindo PharmaIndia | 28 October 2004 |
| 30 tablet, film coated in 1 bottle | 65862-007-30 | Aurobindo PharmaIndia | 28 October 2004 |
| 30 tablet, film coated in 1 blister pack | 65862-007-32 | Aurobindo PharmaIndia | 28 October 2004 |
| 60 tablet, film coated in 1 bottle | 65862-007-60 | Aurobindo PharmaIndia | 28 October 2004 |
| 90 tablet, film coated in 1 bottle | 65862-007-90 | Aurobindo PharmaIndia | 28 October 2004 |
| 30 tablet in 1 bottle | 69097-824-02 | CiplaIndia | 22 July 2016 |
| 100 tablet in 1 bottle | 69097-824-07 | CiplaIndia | 22 July 2016 |
| 500 tablet in 1 bottle | 69097-824-12 | CiplaIndia | 22 July 2016 |
| 1000 tablet in 1 bottle | 69097-824-15 | CiplaIndia | 22 July 2016 |
| 100 tablet, film coated in 1 bottle | 13668-011-01 | Torrent PharmaceuticalsIndia | 18 October 2007 |
| 500 tablet, film coated in 1 bottle | 13668-011-05 | Torrent PharmaceuticalsIndia | 18 October 2007 |
| 2800 tablet, film coated in 1 bottle | 13668-011-08 | Torrent PharmaceuticalsIndia | 18 October 2007 |
| 30 tablet, film coated in 1 bottle | 13668-011-30 | Torrent PharmaceuticalsIndia | 18 October 2007 |
| 30 tablet in 1 bottle | 65162-054-03 | Amneal Pharmaceuticals | 6 April 2010 |
| 100 tablet in 1 bottle | 65162-054-10 | Amneal Pharmaceuticals | 6 April 2010 |
| 1000 tablet in 1 bottle | 65162-054-11 | Amneal Pharmaceuticals | 6 April 2010 |
| 500 tablet in 1 bottle | 65162-054-50 | Amneal Pharmaceuticals | 6 April 2010 |
| 100 tablet, film coated in 1 bottle | 42806-021-01 | Epic Pharma | 20 May 2011 |
| 1000 tablet, film coated in 1 bottle | 42806-021-10 | Epic Pharma | 20 May 2011 |
| 30 tablet, film coated in 1 bottle | 42806-021-30 | Epic Pharma | 20 May 2011 |
| 500 tablet in 1 bottle | 76282-208-05 | Exelan Pharmaceuticals | 1 October 2012 |
| 1000 tablet in 1 bottle | 76282-208-10 | Exelan Pharmaceuticals | 1 October 2012 |
| 30 tablet in 1 bottle | 76282-208-30 | Exelan Pharmaceuticals | 1 October 2012 |
| 90 tablet in 1 bottle | 76282-208-90 | Exelan Pharmaceuticals | 1 May 2017 |
| 100 tablet, film coated in 1 bottle, plastic | 0378-6233-01 | Mylan Pharmaceuticals | 28 July 2008 |
| 500 tablet, film coated in 1 bottle, plastic | 0378-6233-05 | Mylan Pharmaceuticals | 28 July 2008 |
| 30 tablet, film coated in 1 bottle | 50090-3136-0 | A-S Medication Solutions | 13 September 2017 |
| 100 tablet, film coated in 1 bottle | 50090-3136-1 | A-S Medication Solutions | 12 February 2024 |
| 90 tablet, film coated in 1 bottle | 50090-3136-2 | A-S Medication Solutions | 22 August 2018 |
| 30 tablet in 1 bottle | 50090-3208-0 | A-S Medication Solutions | 24 October 2017 |
| 100 tablet in 1 bottle | 50090-3208-1 | A-S Medication Solutions | 26 October 2017 |
| 90 tablet in 1 bottle | 50090-3208-2 | A-S Medication Solutions | 24 October 2017 |
| 30 tablet in 1 bottle | 50090-5175-0 | A-S Medication Solutions | 25 September 2020 |
| 100 tablet in 1 bottle | 50090-5175-1 | A-S Medication Solutions | 25 September 2020 |
| 90 tablet in 1 bottle | 50090-5175-2 | A-S Medication Solutions | 25 September 2020 |
| 90 tablet in 1 bottle | 50090-6947-0 | A-S Medication Solutions | 18 December 2023 |
| 90 tablet, film coated in 1 bottle | 50090-7039-0 | A-S Medication Solutions | 11 January 2024 |
| 15 tablet in 1 bottle | 43353-112-15 | Aphena Pharma Solutions - Tennessee | 9 October 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 July 1998 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Citalopram 40 mg tablet.
Other strengths and forms of Citalopram
Clinical summary
Citalopram is a serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) in adults. It is available as tablets, oral solution and capsules. MedsAcross supplies Citalopram for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CitalopramFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Celexa prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Citalopram 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.